InspireMD, Inc. (NSPR) stock

NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 10/3054% below fair value

$0.64−0.13 (-16.78%)

Close on Nov 13, 2026Market cap $29.94MP/E –Yield –

Earnings

InspireMD's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Mar 17, 2027

Q4 FY2026 · estimated, before the open

Revenue, Q3 FY2026

$2.24M

-10.3% on a year earlier

EPS, Q3 FY2026

-$0.12

-$0.17 a year earlier

Latest guidance

Issued

Mar 18, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of InspireMD's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Source
Q4 FY2026ended Dec 31, 2026	Mar 17, 2027Expected	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Nov 12, 2026after the close	$2.24M	-10.3%	-$0.12	Release
Q2 FY2026ended Jun 30, 2026	Aug 17, 2026before the open	$1.77M	–	-$0.17	Release
Q1 FY2026ended Mar 31, 2026	May 4, 2026during market hours	$3.40M	+122.4%	-$0.16	Release
Q4 FY2025ended Dec 31, 2025	Mar 18, 2026before the open	$3.10M	+59.1%	-$0.14	Release
Q3 FY2025ended Sep 30, 2025	Nov 4, 2025during market hours	$2.50M	–	-$0.17	Release
Q2 FY2025ended Jun 30, 2025	Aug 5, 2025before the open	–	–	-$0.26	Release
Q1 FY2025ended Mar 31, 2025	May 9, 2025before the open	$1.53M	+1.2%	-$0.22	Release
Q4 FY2024ended Dec 31, 2024	Mar 12, 2025before the open	$1.95M	+10.7%	-$0.19	Release
Q2 FY2024ended Jun 30, 2024	Aug 6, 2024before the open	$1.74M	+5.5%	-$0.22	Release
Q1 FY2024ended Mar 31, 2024	May 14, 2024before the open	$1.51M	+22.0%	-$0.21	Release
Q4 FY2023ended Dec 31, 2023	Mar 6, 2024before the open	$1.76M	+71.6%	-$0.16	Release
Q3 FY2023ended Sep 30, 2023	Nov 6, 2023before the open	$1.56M	+8.7%	-$0.15	Release
Q2 FY2023ended Jun 30, 2023	Aug 8, 2023before the open	$1.65M	+7.7%	-$0.24	Release
Q1 FY2023ended Mar 31, 2023	May 16, 2023before the open	$1.24M	+4.7%	-$0.53	Release
Q4 FY2022ended Dec 31, 2022	Mar 30, 2023before the open	$1.03M	-25.7%	-$0.60	Release
Q3 FY2022ended Sep 30, 2022	Nov 8, 2022before the open	$1.43M	+33.6%	-$0.58	Release
Q2 FY2022ended Jun 30, 2022	Aug 11, 2022during market hours	$1.53M	–	-$0.59	Release
Q1 FY2022ended Mar 31, 2022	May 10, 2022before the open	$1.18M	–	-$0.57	Release
Q4 FY2021ended Dec 31, 2021	Mar 8, 2022before the open	$1.38M	–	-$0.53	Release
Q3 FY2021ended Sep 30, 2021	Nov 9, 2021during market hours	$1.07M	–	-$0.53	Release
Q2 FY2021ended Jun 30, 2021	Aug 10, 2021during market hours	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	May 11, 2021before the open	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Mar 10, 2021before the open	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Nov 9, 2020before the open	–	–	–	Filing
Q2 FY2020ended Jun 30, 2020	Aug 5, 2020before the open	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

InspireMD's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
expected revenue growth	FY2026	+45% – +65%	–	New	Mar 18, 2026
revenue	FY2026	$13.00M – $15.00M	–	New	Mar 18, 2026

Guidance history

Every forecast InspireMD put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Mar 18, 2026	expected revenue growth	FY2026	+45% – +65%	New
Mar 18, 2026	revenue	FY2026	$13.00M – $15.00M	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.